penicillamine has been researched along with Nausea in 10 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doses of 600 mg and 1200 mg of D(-)penicillamine daily were superior to a standard regimen of therapy in rheumatoid arthritis." | 9.04 | Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. ( Davies, J; Dixon, AJ; Dormandy, TL; Hamilton, EB; Holt, PJ; Mason, RM; Thompson, M; Weber, JC; Zutshi, DW, 1975) |
| "Sixty-five patients, 33 receiving azathioprine and 32 receiving penicillamine, took part in a one-year, single-blind external-observer trial designed to compare the efficacy and toxicity of these two drugs in the treatment of rheumatoid arthritis." | 9.04 | Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. ( Barnes, CG; Berger, LA; Berry, H; Durance, RA; Evans, S; Liyanage, SP, 1976) |
| "Twenty-three patients with the chronic progressive or intermittent relapsing form of multiple sclerosis (MS) were treated with d-penicillamine over a period from 6 weeks to 12 months." | 9.04 | Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study. ( Cendrowski, W; Czlonkowska, A, 1976) |
| "Nausea was the major side effect in the sulphasalazine treated group." | 6.65 | Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. ( Grindulis, KA; Hubball, S; McConkey, B; Neumann, VC; Wright, V, 1983) |
| "Doses of 600 mg and 1200 mg of D(-)penicillamine daily were superior to a standard regimen of therapy in rheumatoid arthritis." | 5.04 | Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. ( Davies, J; Dixon, AJ; Dormandy, TL; Hamilton, EB; Holt, PJ; Mason, RM; Thompson, M; Weber, JC; Zutshi, DW, 1975) |
| "Sixty-five patients, 33 receiving azathioprine and 32 receiving penicillamine, took part in a one-year, single-blind external-observer trial designed to compare the efficacy and toxicity of these two drugs in the treatment of rheumatoid arthritis." | 5.04 | Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. ( Barnes, CG; Berger, LA; Berry, H; Durance, RA; Evans, S; Liyanage, SP, 1976) |
| "Twenty-three patients with the chronic progressive or intermittent relapsing form of multiple sclerosis (MS) were treated with d-penicillamine over a period from 6 weeks to 12 months." | 5.04 | Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study. ( Cendrowski, W; Czlonkowska, A, 1976) |
| "Nausea was the major side effect in the sulphasalazine treated group." | 2.65 | Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. ( Grindulis, KA; Hubball, S; McConkey, B; Neumann, VC; Wright, V, 1983) |
| "To present a case of Wilson's disease that presented with fatigue, nausea, abdominal pain, and splenomegaly." | 2.43 | A case study: identifying a new case of Wilson's disease. ( Noble, JA, 2005) |
| "To evaluate rates on the adverse side effect and discontinuation of second-line drugs frequently used in the treatment of rheumatoid arthritis (RA)." | 1.31 | [Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs]. ( Jiang, L; Ni, L; Zhao, N, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, L | 1 |
| Zhao, N | 1 |
| Ni, L | 1 |
| Faure, A | 1 |
| Mathon, L | 1 |
| Poupelin, JC | 1 |
| Allaouchiche, B | 1 |
| Chassard, D | 1 |
| Noble, JA | 1 |
| Neumann, VC | 1 |
| Grindulis, KA | 1 |
| Hubball, S | 1 |
| McConkey, B | 1 |
| Wright, V | 1 |
| Dixon, AJ | 1 |
| Davies, J | 1 |
| Dormandy, TL | 1 |
| Hamilton, EB | 1 |
| Holt, PJ | 1 |
| Mason, RM | 1 |
| Thompson, M | 1 |
| Weber, JC | 1 |
| Zutshi, DW | 1 |
| Berry, H | 2 |
| Liyanage, SP | 1 |
| Durance, RA | 1 |
| Barnes, CG | 1 |
| Berger, LA | 1 |
| Evans, S | 1 |
| Cendrowski, W | 1 |
| Czlonkowska, A | 1 |
| Saxer, M | 1 |
| Oeding, A | 1 |
| Kaganas, G | 1 |
| Vogt, E | 1 |
| Huskisson, EC | 2 |
| Gibson, TJ | 1 |
| Balme, HW | 1 |
| Burry, HC | 1 |
| Grahame, R | 1 |
| Hart, FD | 2 |
| Henderson, DR | 1 |
| Wojtulewski, JA | 1 |
1 review available for penicillamine and Nausea
| Article | Year |
|---|---|
A case study: identifying a new case of Wilson's disease.
Topics: Abdominal Pain; Adult; Chelating Agents; Diagnosis, Differential; Drug Monitoring; Drug Therapy, Com | 2005 |
5 trials available for penicillamine and Nausea
| Article | Year |
|---|---|
Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Clinical Trials as Topi | 1983 |
Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
Topics: Acetaminophen; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Dyspepsia; Female; Humans; | 1975 |
Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; Clinical Trials as Topic; Fem | 1976 |
Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study.
Topics: Adult; Ageusia; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Dyspepsia; Erythema; Fem | 1976 |
Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
Topics: Agglutination Tests; Arthritis, Rheumatoid; Blood Sedimentation; Clinical Trials as Topic; Feeding a | 1974 |
4 other studies available for penicillamine and Nausea
| Article | Year |
|---|---|
[Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs].
Topics: Adult; Anorexia; Antirheumatic Agents; Arthritis, Rheumatoid; Exanthema; Female; Gastrointestinal Di | 2002 |
[Acute cupric sulfate intoxication: pathophysiology and therapy about a case report].
Topics: Adult; Chelating Agents; Copper Sulfate; Erythrocyte Transfusion; Hemolysis; Humans; Intellectual Di | 2003 |
[Clinical experiences with d-penicillamine in rheumatoid arthritis (author's transl)].
Topics: Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Nausea; Penicillamine; Proteinuria; Skin M | 1977 |
Penicillamine in the treatment of rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Blood Sedimentation; Gangrene; Humans; Middle Aged; Nausea; Penicillami | 1972 |